L. P. Mcadam, M. A. O'hanlan, and R. Bluestone, Relapsing polychondritis: prospective study of 23 patients and a review of the literature, Medicine (Baltimore), vol.55, pp.193-215, 1976.

J. M. Damiani and H. L. Levine, Relapsing polychondritis, Laryngoscope, vol.89, pp.929-975, 1979.

E. Letko, P. Zafirakis, and S. Baltatzis, Relapsing polychondritis: a clinical review, Semin Arthritis Rheum, vol.31, pp.384-95, 2002.

L. Arnaud, A. Mathian, and J. Haroche, Pathogenesis of relapsing polychondritis: a 2013 update, Autoimmun Rev, vol.13, pp.90-95, 2014.

L. Cantarini, A. Vitale, and M. G. Brizi, Diagnosis and classification of relapsing polychondritis, J Autoimmun, pp.53-62, 2014.

C. J. Michet, C. H. Mckenna, and H. S. Luthra, Relapsing polychondritis. Survival and predictive role of early disease manifestations, Ann Intern Med, vol.104, pp.74-82, 1986.

J. Eng and S. Sabanathan, Airway complications in relapsing polychondritis, Ann Thorac Surg, vol.51, pp.686-92, 1991.

M. Carrión, J. A. Girón, and J. Ventura, Airway complications in relapsing polychondritis, J Rheumatol, vol.20, pp.1628-1637, 1993.

T. Lahmer, M. Treiber, V. Werder, and A. , Relapsing polychondritis: an autoimmune disease with many faces, Autoimmun Rev, vol.9, pp.540-546, 2010.

K. Lekpa, F. Kraus, V. B. Chevalier, and X. , Biologics in relapsing polychondritis: a literature review, Semin Arthritis Rheum, vol.41, pp.712-721, 2012.

V. B. Kraus, T. Stabler, and E. T. Le, Urinary type II collagen neoepitope as an outcome measure for relapsing polychondritis, Arthritis Rheum, vol.48, pp.2942-2950, 2003.

S. Mpofu, C. Estrach, and J. Curtis, Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab, Rheumatology, vol.42, pp.1117-1125, 2003.

C. Richez, C. Dumoulin, and X. Coutouly, Successful treatment of relapsing polychondritis with infliximab, Clin Exp Rheumatol, vol.22, pp.629-660, 2004.

S. Cazabon, K. Over, and J. Butcher, The successful use of infliximab in resistant relapsing polychondritis and associated scleritis, Eye, vol.19, pp.222-226, 2005.

S. Ghosn, J. Malek, and Z. Shbaklo, Takayasu disease presenting as malignant pyoderma gangrenosum in a child with relapsing polychondritis, J Am Acad Dermatol, vol.59, pp.84-91, 2008.

P. Subrahmanyam, C. Balakrishnan, and B. Dasgupta, Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia, Scand J Rheumatol, vol.37, pp.239-279, 2008.

M. Kawai, K. Hagihara, and T. Hirano, Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis, Rheumatology, vol.48, pp.318-327, 2009.

I. Marie, L. Lahaxe, and S. Josse, Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement, Rheumatology (Oxford), vol.48, pp.1328-1337, 2009.

Ö. N. Pamuk, F. Harmandar, and N. Çakir, The development of trigeminal neuralgia related to auricular chondritis in a patient with rheumatoid arthritis -relapsing polychondritis and its treatment with etanercept. Description of first case, Clin Exp Rheumatol, vol.27, pp.128-137, 2009.

G. Ratzinger, M. Kuen-spiegl, and N. Sepp, Successful treatment of recalcitrant relapsing polychondritis with monoclonal antibodies, J Eur Acad Dermatol Venereol, vol.23, pp.474-479, 2009.

A. P. De-barros, N. A. Nakamura, S. Tde, and F. , Infliximab in relapsing polychondritis, Rev Bras Reumatol, vol.50, pp.211-215, 2010.

P. S. Buonuomo, C. Bracaglia, and A. Campana, Relapsing polychondritis: new therapeutic strategies with biological agents, Rheumatol Int, vol.30, pp.691-694, 2010.

E. D. Geissal and R. Wernick, A case of severe MAGIC syndrome treated successfully with the tumor necrosis factor-alpha inhibitor infliximab, J Clin Rheumatol, vol.16, pp.185-192, 2010.

T. Lahmer, A. Knopf, and M. Treiber, Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab, Clin Rheumatol, vol.29, pp.1331-1335, 2010.

G. Moulis, L. Sailler, and L. Astudillo, Abatacept for relapsing polychondritis, Rheumatology (Oxford), vol.49, p.1019, 2010.

M. V. Hernández, V. Ruiz-esquide, and M. E. Gómez-caballero, Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?, Rheumatology (Oxford), vol.50, pp.1523-1528, 2011.

S. Keidel, A. Mccoll, and S. Edmonds, Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis, BMJ Case Rep, 2011.

H. Nakamura, T. Suzuki, and K. Nagaoka, Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of proinflammatory cytokines, Mod Rheumatol, vol.21, pp.665-673, 2011.

R. Abdwani and A. A. Kolethekkat, Al Abri R. Refractory relapsing polychondritis in a child treated with antiCD20 monoclonal antibody (rituximab): first case report, Int J Pediatr Otorhinolaryngol, vol.76, pp.1061-1065, 2012.

R. Adamson, Y. Yazici, and E. S. Katz, Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis, J Clin Rheumatol, vol.19, pp.386-395, 2013.

A. R. Fonseca, D. Oliveira, S. Rodrigues, and M. , Relapsing polychondritis in childhood: three case reports, comparison with adulthood disease and literature review, Rheumatol Int, vol.33, pp.1873-1881, 2013.

Z. S. Wallace and J. H. Stone, Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade, J Rheumatol, vol.40, pp.100-101, 2013.

E. Weber, J. Gaultier, and S. Paul, Sustained response with tocilizumab in a case of refractory relapsing polychondritis, Rev Med Interne, vol.35, pp.196-204, 2014.

J. C. Henes, T. Xenitidis, and M. Horger, Tocilizumab for refractory relapsing polychondritis-long-term response monitoring by magnetic resonance imaging, Joint Bone Spine, vol.83, pp.365-371, 2016.

G. Vitiello, B. Palterer, and P. Parronchi, Tocilizumab-induced mucosal ulcers in a patient with relapsing polychondritis: an adverse drug reaction?, Semin Arthritis Rheum, vol.46, pp.9-10, 2016.

A. Ernst, S. Rafeq, and P. Boiselle, Relapsing polychondritis and airway involvement, Chest, vol.135, pp.1024-1054, 2009.

G. Hong and H. Kim, Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement, Clin Rheumatol, vol.32, pp.1329-1364, 2013.

T. Wallaert, B. Leblond, and D. , Respiratory involvement in relapsing polychondritis: clinical, functional, endoscopic, and radiographic evaluations, Medicine (Baltimore), vol.77, pp.168-76, 1998.

Z. Mohsenifar, D. P. Tashkin, and S. A. Carson, Pulmonary function in patients with relapsing polychondritis, Chest, vol.81, pp.711-718, 1982.

K. S. Lee, A. Ernst, and D. E. Trentham, Relapsing polychondritis: prevalence of expiratory CT airway abnormalities, Radiology, vol.240, pp.565-73, 2006.

L. Arnaud, H. Devilliers, and S. L. Peng, The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis, Autoimmun Rev, vol.12, pp.204-213, 2012.

H. Yamashita, H. Takahashi, and K. Kubota, Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review, Rheumatology (Oxford), vol.53, pp.1482-90, 2014.

J. Wang, S. Li, and Y. Zeng, 18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring, Ann Nucl Med, vol.28, pp.276-84, 2014.

. Biya, , vol.98, p.44, 2019.